A Critical Risk-Benefit Assessment Argues Against the Use of Anthracyclines in Induction Regimens for Newly Diagnosed Childhood Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

A Critical Risk-Benefit Assessment Argues Against the Use of Anthracyclines in Induction Regimens for Newly Diagnosed Childhood Acute Lymphoblastic Leukemia

Published:1999-01 Issue:5-6 Volume:34 Page:415-432
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Messinger Yoav,Uckun Fatih M.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199909058469

Reference122 articles.

1. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type

2. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

3. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

4. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors;Cancer Reports;2023-03-28

2. Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: high mortalities, early relapses, and poor survival;Jornal de Pediatria;2020-01

3. Treatment outcomes of children with acute lymphoblastic leukemia in a middle‐income developing country: high mortalities, early relapses, and poor survival;Jornal de Pediatria (Versão em Português);2020-01

4. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer;Cochrane Database of Systematic Reviews;2014-09-04

5. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer;Cochrane Database of Systematic Reviews;2011-01-19